Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Cladribine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,473Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hopewell’s Generics Cladribine Receives Tentative Approval in US
    Hopewell’s Generics Cladribine Receives Tentative Approval in US

    04 Dec 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215547

    FDA
    04 Dec 2025
    Share Share
    Bionxt Secures Eurasian Patent For Sublingual MS Therapy
    Bionxt Secures Eurasian Patent For Sublingual MS Therapy

    24 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/bionxt-secures-eurasian-patent-for-breakthrough-sublingual-ms-therapy-18336

    INDPHARMAPOST
    24 Nov 2025
    Share Share
    EMD Serono Innovates Rare Neuromuscular Disorder Treatment
    EMD Serono Innovates Rare Neuromuscular Disorder Treatment

    24 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251124788420/en/EMD-Serono-Takes-Patient-Directed-Approach-to-Bring-Innovation-to-the-Treatment-of-Rare-Neuromuscular-Disorder-Generalized-Myasthenia-Gravis

    BUSINESSWIRE
    24 Nov 2025
    Share Share
    Bionxt Secures Eurasian Patent For Sublingual Cladribine Platform
    Bionxt Secures Eurasian Patent For Sublingual Cladribine Platform

    20 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-20/bionxt-secures-final-patent-grant-from-the-eurasian-patent-organization-for-sublingual-cladribine-pl

    PHARMIWEB
    20 Nov 2025
    Share Share
    BioNxt Gets EPO Intention to Grant for Oral Cladribine Film
    BioNxt Gets EPO Intention to Grant for Oral Cladribine Film

    04 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-04/bionxt-reports-intention-to-grant-patent-notification-from-the-european-patent-office-for-its-oral

    PHARMIWEB
    04 Nov 2025
    Share Share
    BioNxt Gets Eurasian Patent Readiness to Grant Notification
    BioNxt Gets Eurasian Patent Readiness to Grant Notification

    30 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-30/bionxt-reports-readiness-to-grant-patent-notification-from-the-eurasian-patent-organization

    PHARMIWEB
    30 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.